sibutramine has been researched along with Anxiety in 6 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sibutramine is an anorexiant drug that inhibits the reuptake of noradrenaline and serotonin, a pharmacological property shared with drugs clinically effective in treating anxiety pathologies." | 7.72 | Effects of sibutramine on anxiety-related behaviours in rats. ( de Oliveira, AM; de Paula Soares, V; Jorge, SD; Pobbe, RL; Zangrossi, H, 2004) |
| "Sibutramine is an anorexiant drug that inhibits the reuptake of noradrenaline and serotonin, a pharmacological property shared with drugs clinically effective in treating anxiety pathologies." | 3.72 | Effects of sibutramine on anxiety-related behaviours in rats. ( de Oliveira, AM; de Paula Soares, V; Jorge, SD; Pobbe, RL; Zangrossi, H, 2004) |
| "Sibutramine is a serotonin and norepinephrine reuptake inhibitor indicated for the treatment of obesity." | 1.40 | Evaluation of the effect of acute sibutramine in female rats in the elevated T-maze and elevated plus-maze tests. ( André, E; de Assunção, GL; de Barros, KS; de Medeiros, DM; de Paula Soares-Rachetti, V; de Sousa Pinto, IA; Gavioli, EC; Santos, RO; Soares, BL, 2014) |
| " They started with a dosage of 1 capsule per day, gradually increasing the Meizitanc dose to 3 capsules a day." | 1.34 | [Side effects after the usage of Chinese dieting product Meizitanc]. ( Chodorowski, Z; Sein Anand, J, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santos, RO | 1 |
| de Assunção, GL | 1 |
| de Medeiros, DM | 1 |
| de Sousa Pinto, IA | 1 |
| de Barros, KS | 1 |
| Soares, BL | 1 |
| André, E | 1 |
| Gavioli, EC | 1 |
| de Paula Soares-Rachetti, V | 1 |
| Frassetto, SS | 1 |
| Alves, IO | 1 |
| Santos, MM | 1 |
| Schmidt, AE | 1 |
| Lopes, JJ | 1 |
| Oliveira, PA | 1 |
| Vinagre, AS | 1 |
| Pereira, P | 1 |
| Jorge, SD | 1 |
| Pobbe, RL | 1 |
| de Paula Soares, V | 1 |
| de Oliveira, AM | 1 |
| Zangrossi, H | 1 |
| Sein Anand, J | 1 |
| Chodorowski, Z | 1 |
| Yilmaz, Y | 1 |
| Aylwin, S | 1 |
| Al-Zaman, Y | 1 |
1 review available for sibutramine and Anxiety
| Article | Year |
|---|---|
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Baria | 2008 |
5 other studies available for sibutramine and Anxiety
| Article | Year |
|---|---|
Evaluation of the effect of acute sibutramine in female rats in the elevated T-maze and elevated plus-maze tests.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Cyclobutanes; Drug Evaluation, Preclinica | 2014 |
Absence of sibutramine effect on spontaneous anxiety in rats.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anti-Obesity Agents; Anxiety; Body Weight; Cyclo | 2010 |
Effects of sibutramine on anxiety-related behaviours in rats.
Topics: Animals; Anxiety; Cyclobutanes; Darkness; Disease Models, Animal; Dose-Response Relationship, Drug; | 2004 |
[Side effects after the usage of Chinese dieting product Meizitanc].
Topics: Adult; Anti-Obesity Agents; Anxiety; Body Mass Index; Consumer Product Safety; Cyclobutanes; Diet, R | 2007 |
Psychopathology in the context of obesity: the adiponectin hypothesis.
Topics: Adiponectin; Anxiety; Cyclobutanes; Depression; Headache; Humans; Migraine Disorders; Models, Biolog | 2008 |